Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Advanced Orthopedic Technologies Market size was valued at USD 62.9 billion in 2024 and is projected to exceed USD 148.5 billion by the end of 2037, expanding at over 6.9% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of advanced orthopedic technologies is estimated at USD 67.3 billion.
The market is highly driven by an increase in the need for minimally invasive surgeries, robotic-based orthopedic procedures, and smart implant technologies. Besides, the patient pool aspect is also ensuring market expansion owing to the presence of an aging demographic and a rise in musculoskeletal diseases. According to a report published by the World Health Organization (WHO), more than 1.8 billion people are affected by the disorder, out of which an estimated 530 million people suffer from osteoarthritis internationally, thereby driving the demand for orthobiologics and joint replacement procedures.
Furthermore, the supply chain system for orthopedic biologics and devices is yet another factor positively impacting the market internationally. This system effectively relies on specific raw materials, which include polyethylene, medical-grade titanium, and other biologics such as demineralized bone matrix (DBM). Besides, the U.S. International Trade Commission (USITC) denoted that Mexico, Germany, and China are major exporters of orthopedic components, while the U.S. imports approximately USD 3.2 billion in orthopedic devices every year. Also, the producer price index for surgical appliances increased by 4.2% on a yearly basis, thereby suitable for the market upliftment.
Advanced Orthopedic Technologies Sector: Growth Drivers and Challenges
Growth Drivers
- Reimbursement and government expenditure: The aspect of administrative funding and reimbursement policies significantly drives the advanced orthopedic technologies market. For instance, the Medicare spending in the U.S. for orthopedic procedures has reached USD 24.6 billion in 2023, out of which 62.5% of total expenditures are covered for hip and knee replacements. Besides, the approval of robotic-assisted surgical devices by the FDA has escalated the market entry, with the clearance of 12 latest orthopedic robots in 2024, thereby suitable for market upliftment globally.
- Rise in elderly population: This is one of the major growth drivers for amplifying the market. As per an article published by the WHO, an estimated 1 in 7 people worldwide will be more than 60 years of age, positively driving the increasing requirement for fracture repair and joint replacements. Besides, as stated in the CDC report, approximately 25% of adults suffer from arthritis, with an increase in the incidence of total knee replacement by 190% by the end of the forecast period. Moreover, Germany recorded 2.4 million people being affected by osteoarthritis in 2025, denoting a 23% increase since previous years.
Key Historical Patient Growth Analysis for the Market Expansion
The global market is fundamentally shaping its position through sustained patient pool development across different nations. Improved diagnostic capabilities, a rise in sports injuries, and the aging population are all undergoing effective development owing to the demand for orthopedic interventions. Besides, the Affordable Care Act (ACA) and Medicare expansion have improved joint replacement accessibility in the U.S., while Japan and Germany observed an acceleration in the implementation due to domestically funded healthcare mandates. In addition, developing markets such as China and India are experiencing rapid evolution owing to trauma cases, urbanization, and escalated medical facilities.
Advanced Orthopedic Technologies Users Comparison Between 2014 and 2024
|
Country |
2014 Patients (Million) |
2024 Patients (Million) |
Key Driver |
|
USA |
12.5 |
19.1 |
Medicare expansion, obesity rates |
|
Germany |
5.3 |
7.9 |
Aging population, robotic surgery adoption |
|
France |
4.1 |
5.7 |
Public healthcare coverage |
|
Spain |
2.8 |
4.2 |
Medical tourism for joint replacements |
|
Australia |
1.9 |
3.1 |
Sports injury surge |
|
Japan |
6.6 |
9.4 |
Super-aging society |
|
India |
8.5 |
22.8 |
Trauma cases, private hospital growth |
|
China |
14.3 |
31.6 |
Urbanization, rising osteoarthritis |
Key Feasible Expansion Models for Shaping the Advanced Orthopedic Technologies Market
The market is undergoing rapid transformation, which is highly facilitated by models that ensure expansion and align with regional healthcare dynamics. For instance, the strategic partnership between localized hospital centers and global manufacturers has enhanced revenue by 12.5% between 2014 and 2024 by enhancing trauma implants accessibility. On the other hand, the U.S. region observed an increase in revenue by 8.4% in 2023 through ASC-specific robotic surgery bundles. Likewise, the value-specified procurement diminished implant costs by an estimated 15.5%, while maintaining and balancing out the overall quality, thereby creating a prolific opportunity for market expansion.
Feasibility Models for Market Expansion
|
Model |
Region |
Revenue Impact |
Cost Savings |
|
Local OEM Partnerships |
India |
+12.5% (2022–2024) |
20.2% lower MSP |
|
Medicare CJR Bundles |
USA |
+8.8% (2023) |
12.5% per episode |
|
Tiered Pricing Contracts |
Germany |
+5.9% (2024) |
15.7% implant cost |
Challenges
- Barriers in government and decompensation: The presence of stringent price regulations has limited profitability for global manufacturers, thus causing a hindrance to the advanced orthopedic technologies market. For instance, in Germany, the G-BA has enforced compulsory price caps on orthopedic implants, which have resulted in reduced margins by 21% to 26%. Likewise, in the U.S., Medicaid provides coverage of only 35.5% of innovative orthopedic procedures owing to huge cost strategies. Even organizations, such as Zimmer Biomet, successfully navigated this issue by providing value-based contracts with EU hospitals that have enhanced market access by 10.8%.
- Lengthy regulatory acceptances: The aspect of strict EU MDR and FDA approvals usually delays product launches, which creates a negative impact on the market. For instance, in 2024, the EU MDR enhanced the demand for clinical evidence, resulting in a six-month delay for almost 41% of orthopedic devices. However, companies such as Medtronic PLC overcame this challenge by achieving the FDA Breakthrough Device designation for its artificial intelligence-based knee implant, thus accelerating approval by 31% and positively driving market expansion.
Advanced Orthopedic Technologies Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.9% |
|
Base Year Market Size (2024) |
USD 62.9 billion |
|
Forecast Year Market Size (2037) |
USD 148.5 billion |
|
Regional Scope |
|
Advanced Orthopedic Technologies Segmentation
Application (Osteoarthritis, Sports Injuries, Trauma & Fractures, Rheumatoid Arthritis, Pediatric Orthopedics)
The osteoarthritis segment is anticipated to account for the largest share of 46.9% in the market by the end of 2037. This dominance is facilitated by the existence of irreversible demographic trends, since the elderly population is continuously expanding across different nations. For instance, 32% to 37% of seniors in Germany and Japan particularly face the acute burden of the disease, especially those affected by symptomatic osteoarthritis. Besides, the direct correlation with obesity and aging for the disease accounts for 41% of the U.S. osteoarthritis cases to be obesity-based, thus driving the segment’s growth.
Product (Implants (42%), Surgical Devices, Orthobiologics, Trauma Fixation, Prosthetics, Braces & Supports)
The implants segment is projected to hold the second-largest share of 42.5% in the advanced orthopedic technologies market during he forecast timeline. This segment’s growth is effectively driven by the increasing burden of osteoarthritis, with more than 505 million cases internationally, along with a rise in the adoption of robot-assisted and customized implants. Besides these drivers, the aspect of technological innovation, including cementless hip stems and 3D-printed titanium implants, is also accelerating the segment’s growth. However, the presence of price caps under national health insurance schemes tends to suppress profit margins by almost 10.3% to 15.7%, thereby forcing manufacturers to implement value-based contracts.
Our in-depth analysis of the global market includes the following segments:
|
Application |
|
|
Product |
|
|
End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportAdvanced Orthopedic Technologies Industry - Regional Synopsis
North America Market Analysis
North America in the advanced orthopedic technologies market is projected to hold the largest share of 42.9% by the end of the forecast timeline. This regional development is highly driven by an increase in healthcare and medical expenditure, with the U.S. and Canada jointly investing an estimated USD 12.6 billion in orthopedic care. Besides this, administrative and government investment, the utilization of robotic orthopedic systems, and the aging demographics are other key drivers that are positively impacting the market development in the region.
The advanced orthopedic technologies market in the U.S. holds almost 32.5% of the overall regional revenue, effectively attributed to Medicare orthopedic spending of approximately USD 8.5 million as of 2024. In addition, the availability of robotic surgeries also accounts for USD 508.7 billion in similar spending during the same timeline for almost 505,500 devices. Besides all these factors, artificial intelligence diagnostics, expansion in ASCs, and value-based care facilities are other key trends that ensure a positive outlook for the market evolution in the country.
The advanced orthopedic technologies market in Canada is also significantly growing, owing to its market expansion at a 4.8% growth rate, along with an investment of USD 3.7 billion for the provision of orthopedic care facilities as of 2024. Besides, Ontario is effectively leading with a fund allocation of 26%, pertaining to national procedures, but the waiting timeline usually ranges from 8.5 months. The implications of indigenous health, tele-rehabilitation, and biosimilar adoption are other essential drivers that are readily amplifying the market upliftment in the country.
Europe Regional Market Size & Growth
Europe in the advanced orthopedic technologies market is projected to hold a share of 32.4% by the end of 2037. The region’s more than 65 years of demographic is expected to increase by 25.8% by 2035, which is attributed to the availability of joint replacement services, especially in France and Germany. In addition, the existence of EU politics, including a €2.7 billion fund provision by the Health Data Space initiative, is also accelerating the artificial intelligence evolution, and meanwhile, price caps under the EU MDR restrict profit margin by 17% to 21%. Besides, Germany is leading with robotic penetration in almost 40.7% of hospitals, while the UK’s NHS ensures 90.5% of coverage for trauma implantation procedure, thus driving market growth in the region.
The advanced orthopedic technologies market in Germany accounts for 33% of the region’s market revenue, effectively facilitated by world-leading robotic surgery implementation and a rising aging population. Additionally, the country’s €4.3 billion orthopedic market also benefits from the robust presence of administrative support, which includes federal funding of €210 million for 3D-printed implants. Despite these growth factors, G-BA price caps have flattened domestic manufacturer margins by 20.2% since 2022, thereby creating a balanced impact on the market in the country.
The advanced orthopedic technologies market in France is projected to account for almost 22.7% of the regional market share by the end of the forecast period. This growth is possible to achieve by the accelerated utilization of ASCs, which caters to 31% of procedures by 2030, as well as an increase in the adoption of biosimilars, which denotes an estimated €120.8 million in yearly savings. Moreover, the country also allocated 7.5% of its €180.6 billion healthcare budget, that is €12.8 billion, to orthopedic products and services, thus suitable for ensuring market expansion in the country.
Competitive Landscape & Strategic Initiatives
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The advanced orthopedic technologies market is mainly driven by key companies that efficiently leverage biologics, artificial intelligence-specified implantation procedures, and robotics with the objective of maintaining leadership. For instance, Zimmer Biomet and Stryker are effectively leading with a combined 35.8% of the global share, with special focus on robotic surgery systems. In addition, organizations in Europe, such as Smith & Nephew, concentrate on minimally invasive solutions, while companies in India, including Meril Life, and South Korea’s Corentec are also contributing towards the market upliftment.
Here is a list of key players operating in the global market:
|
Company Name |
Country |
Market Share (2024) |
Industry Focus |
|
Stryker Corporation |
U.S. |
22.2% |
Robotics (Mako), trauma implants, 3D-printed prosthetics |
|
Zimmer Biomet |
U.S. |
13.3% |
Joint replacements, ROSA robotic surgery, biologics |
|
Johnson & Johnson (DePuy Synthes) |
U.S. |
11.1% |
Knee/hip implants, trauma fixation, AI-powered surgical tools |
|
Medtronic |
Ireland |
9.5% |
Spine implants, robotic navigation (Mazor X) |
|
Smith & Nephew |
UK |
7.8% |
Arthroscopy, advanced wound care, CORI surgical robot |
|
Siemens Healthineers |
Germany |
xx% |
AI-based orthopedic imaging, surgical planning |
|
B. Braun |
Germany |
xx% |
Bone cement, spinal devices |
|
DJO Global |
U.S. |
xx% |
Bracing, regenerative therapies (Bioventus) |
|
Exactech |
U.S. |
xx% |
Shoulder/knee implants, augmented reality surgical tools |
|
Corin Group |
UK |
xx% |
Hip resurfacing, personalized implants |
|
Meril Life Sciences |
India |
xx% |
Low-cost trauma implants, bioresorbable scaffolds |
|
Corentec |
South Korea |
xx% |
Smart knee implants, robotic-assisted surgery |
|
Orthocell |
Australia |
xx% |
Tendon repair biologics, stem cell therapies |
|
Osteopore |
Singapore |
xx% |
3D-printed bone grafts |
|
FH Orthopedics |
France |
xx% |
Foot/ankle solutions, custom orthopedic devices |
Below are the areas covered for each company under the top 20 global manufacturers:
In the News
- In January 2024, Stryker Corporation unveiled the Q Guidance System with AI-based spinal surgery navigation, which has gained FDA clearance and has the ability to reduce the procedural time by an estimated 30.2%.
- In June 2023, Smith & Nephew and Google Cloud partnered with each other to effectively integrate artificial intelligence into Smith & Nephew’s CORI Surgical Robot, which can enable predictive analysis for knee replacements.
Author Credits: Radhika Pawar
- Report ID: 7703
- Published Date: May 28, 2025
- Report Format: PDF, PPT
